Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 SEK | +11.51% |
|
+19.23% | -28.07% |
Business Summary
Number of employees: 6
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Lipid-related Drugs
100.0
%
| 0 | nan % | 16 | 100.0 % | - |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 0 | nan % | 16 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 45 | 10-04-05 | |
Lars Ole Öhman
CHM | Chairman | 67 | 11-12-31 |
Hugo Petit
DFI | Director of Finance/CFO | 54 | 22-12-31 |
Eva Arlander
COO | Chief Operating Officer | 60 | 20-12-31 |
Andreas Vretblom
AUD | Comptroller/Controller/Auditor | - | - |
Stefan Pierrou
PRN | Corporate Officer/Principal | 59 | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Ole Öhman
CHM | Chairman | 67 | 11-12-31 |
Director/Board Member | 52 | 20-12-31 | |
David Westberg
BRD | Director/Board Member | 64 | 22-12-31 |
Director/Board Member | 61 | 22-05-18 | |
Johannes Hulthe
BRD | Director/Board Member | 54 | 19-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 126,422,281 | 89,026,825 ( 70.42 %) | 0 | 70.42 % |
Company contact information
![address Lipigon Pharmaceuticals AB(LPGO)](https://cdn.zonebourse.com/static/address/119661045.png)
Sector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.07% | 3.74M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- LPGO Stock
- Company Lipigon Pharmaceuticals AB